Boston Scientific Corp (NYSE:BSX) has a beta value of 0.67 and has seen 0.98 million shares traded in the recent trading session. The company, currently valued at $152.83B, closed the recent trade at $103.3 per share which meant it lost -$1.03 on the day or -0.99% during that session. The BSX stock price is -4.09% off its 52-week high price of $107.53 and 30.42% above the 52-week low of $71.88. If we look at the company’s 10-day average daily trading volume, we find that it stood at 6.78 million shares traded. The 3-month trading volume is 7.39 million shares.
The consensus among analysts is that Boston Scientific Corp (BSX) is Buy stock at the moment, with a recommendation rating of 1.34. 0 analysts rate the stock as a Sell, while 1 rate it as Overweight. 1 out of 15 have rated it as a Hold, with 13 advising it as a Buy. 0 have rated the stock as Underweight.
Boston Scientific Corp (NYSE:BSX) trade information
Sporting -0.99% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BSX stock price touched $103.3 or saw a rise of 1.8%. Year-to-date, Boston Scientific Corp shares have moved 34.35%, while the 5-day performance has seen it change 0.87%. Over the past 30 days, the shares of Boston Scientific Corp (NYSE:BSX) have changed 4.81%. Short interest in the company has seen 17.49 million shares shorted with days to cover at 2.28.
Wall Street analysts have a consensus price target for the stock at $118, which means that the shares’ value could jump 12.46% from the levels at last check today.. The projected low price target is $115.0 while the price target rests at a high of $130.0. In that case, then, we find that the latest price level in today’s session is -25.85% off the targeted high while a plunge would see the stock gain -11.33% from the levels at last check today..
Boston Scientific Corp (BSX) estimates and forecasts
The company’s shares have gained 8.87% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -17.84% over the past 5 years. Earnings growth for 2025 is a modest 16.33% while over the next 5 years, the company’s earnings are expected to increase by 14.04%.
BSX Dividends
Boston Scientific Corp is expected to release its next earnings report on 2025-Apr-23 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Boston Scientific Corp (NYSE:BSX)’s Major holders
Insiders own 0.18% of the company shares, while shares held by institutions stand at 93.22% with a share float percentage of 93.39%. Investors are also buoyed by the number of investors in a company, with Boston Scientific Corp having a total of 2280.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 141.46 million shares worth more than $10.89 billion. As of 2024-06-30, FMR LLC held 9.6192% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 129.87 million shares as of 2024-06-30. The firm’s total holdings are worth over $10.0 billion and represent 8.8311% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund . As of Mar 31, 2025 , the former fund manager holds about 3.15% shares in the company for having 46.63 shares of worth $4.83 billion while later fund manager owns 40.95 shares of worth $4.24 billion as of Mar 31, 2025 , which makes it owner of about 2.77% of company’s outstanding stock.
